Alerts
Other content recommended for you
- A Plutocratic Proposal: an ethical way for rich patients to pay for a place on a clinical trial
- Donor-funded research: permissible, not perfect
- Acceptability of donor funding for clinical trials in the UK: a qualitative empirical ethics study using focus groups to elicit the views of research patient public involvement group members, research ethics committee chairs and clinical researchers
- From protection to entitlement: selecting research subjects for early phase clinical trials involving breakthrough therapies
- Biomedical conflicts of interest: a defence of the sequestration thesis—learning from the cases of Nancy Olivieri and David Healy
- Fair, just and compassionate: A pilot for making allocation decisions for patients requesting experimental drugs outside of clinical trials
- The role of clinical trials in the sustainability of the Italian national health service cancer drug expenditure
- Achieving equal and timely access to innovative anticancer drugs in the European Union (EU): summary of a multidisciplinary CECOG-driven roundtable discussion with a focus on Eastern and South-Eastern EU countries
- Towards the patient revolution
- Engaging African ancestry participants in SLE clinical trials